• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒16型核蛋白E7免疫原性决定簇的定义

Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7.

作者信息

Altmann A, Jochmus-Kudielka I, Frank R, Gausepohl H, Moebius U, Gissmann L, Meuer S C

机构信息

Department of Applied Immunology, German Cancer Research Centre, Heidelberg.

出版信息

Eur J Cancer. 1992;28(2-3):326-33. doi: 10.1016/s0959-8049(05)80047-4.

DOI:10.1016/s0959-8049(05)80047-4
PMID:1375481
Abstract

Specific T lymphocyte lines and T cell clones were established from peripheral blood mononuclear cells of asymptomatic seropositive individuals employing synthetic peptides which correspond to the sequence of the human papillomavirus (HPV) type 16 transforming protein E7. Specificity analysis of T cells as determined by means of [3H] thymidine incorporation after stimulation with individual peptides revealed three immunogenic determinants of E7 that are recognised in association with at least two different HLA haplotypes. One N-terminal region (aminoacids 5-18) was recognised by one T cell line. T cell clones and the corresponding T cell line established from another donor responded to a different N-terminal (17-38) and to a C-terminal region (69-86). The N-terminal sequence 5-18 and the C-terminal determinant contain a periodicity of hydrophilic and hydrophobic residues that have been found in many T cell epitopes. Phenotypic characterisation of T cell clones by indirect immunofluorescence revealed that the T cell clones expressed the CD4 surface glycoprotein suggesting that the specific E7 determinants were recognised in association with major histocompatibility complex (MHC) class II molecules. With regard to functional properties, at least three T cell clones exhibited specific cytotoxic activity towards autologous B lymphocytes transformed by Epstein-Barr virus in the presence of the relevant HPV16 E7 peptides. The implications of these results regarding the development of vaccination strategies and host-virus interaction are discussed.

摘要

利用与人乳头瘤病毒(HPV)16型转化蛋白E7序列相对应的合成肽,从无症状血清阳性个体的外周血单核细胞中建立了特异性T淋巴细胞系和T细胞克隆。通过用单个肽刺激后[3H]胸苷掺入法测定的T细胞特异性分析显示,E7有三个免疫原性决定簇,它们与至少两种不同的HLA单倍型相关被识别。一个N端区域(氨基酸5 - 18)被一个T细胞系识别。从另一个供体建立的T细胞克隆和相应的T细胞系对不同的N端(17 - 38)和一个C端区域(69 - 86)有反应。N端序列5 - 18和C端决定簇含有亲水性和疏水性残基的周期性,这在许多T细胞表位中都有发现。通过间接免疫荧光对T细胞克隆进行表型特征分析显示,T细胞克隆表达CD4表面糖蛋白,提示特异性E7决定簇与主要组织相容性复合体(MHC)II类分子相关被识别。关于功能特性,至少三个T细胞克隆在相关HPV16 E7肽存在的情况下,对经爱泼斯坦 - 巴尔病毒转化的自体B淋巴细胞表现出特异性细胞毒性活性。讨论了这些结果对疫苗接种策略发展和宿主 - 病毒相互作用的意义。

相似文献

1
Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7.人乳头瘤病毒16型核蛋白E7免疫原性决定簇的定义
Eur J Cancer. 1992;28(2-3):326-33. doi: 10.1016/s0959-8049(05)80047-4.
2
Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16.人乳头瘤病毒16型E7蛋白T细胞和B细胞表位的鉴定
J Virol. 1991 Sep;65(9):4681-90. doi: 10.1128/JVI.65.9.4681-4690.1991.
3
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.通过对HLA-A*0201结合肽的体内和体外免疫原性研究鉴定出的人乳头瘤病毒16型E6和E7编码的人CTL表位。
J Immunol. 1995 Jun 1;154(11):5934-43.
4
T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.在与宫颈癌相关的16型人乳头瘤病毒E6转化蛋白中鉴定出的辅助性T细胞表位。
Viral Immunol. 1999;12(4):297-312. doi: 10.1089/vim.1999.12.297.
5
A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.人乳头瘤病毒16型E7转化蛋白的一个“公共”辅助性T细胞表位为来自宫颈癌相关人乳头瘤病毒基因型的多个E7 B细胞表位提供同源辅助。
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5887-91. doi: 10.1073/pnas.88.13.5887.
6
Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein.人乳头瘤病毒E7蛋白细胞毒性T淋巴细胞表位图谱所揭示的预测基序的局限性
Int Immunol. 1994 Feb;6(2):289-96. doi: 10.1093/intimm/6.2.289.
7
Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes.在上皮中表达人乳头瘤病毒16型(HPV16)E7癌基因的小鼠,对E7编码的细胞毒性T淋巴细胞表位表现出中枢耐受以及外周无反应性耐受的证据。
Virology. 1998 May 10;244(2):352-64. doi: 10.1006/viro.1998.9128.
8
Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.人乳头瘤病毒16型(HPV16)阳性宫颈病变患者针对HPV16 E7衍生肽表位的天然辅助性T细胞免疫:3种人类白细胞抗原II类限制性表位的鉴定
Int J Cancer. 2001 Mar 1;91(5):612-8. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1119>3.0.co;2-c.
9
Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.人乳头瘤病毒33型E7肽由HLA-DR*0402呈递给宫颈癌中的肿瘤浸润性T细胞。
J Virol. 2000 Jul;74(14):6632-6. doi: 10.1128/jvi.74.14.6632-6636.2000.
10
Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein.人乳头瘤病毒16型E7开放阅读框蛋白中B表位的鉴定
J Gen Virol. 1990 Jun;71 ( Pt 6):1347-54. doi: 10.1099/0022-1317-71-6-1347.

引用本文的文献

1
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers.强效、选择性的嵌合抗原受体作为 HPV 阳性癌症的潜在 T 细胞治疗方法。
J Immunother. 2021 Oct 1;44(8):292-306. doi: 10.1097/CJI.0000000000000386.
2
T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.不同级别宫颈肿瘤女性中针对16型人乳头瘤病毒的T细胞反应。
Br J Cancer. 2005 Jul 25;93(2):248-59. doi: 10.1038/sj.bjc.6602679.
3
Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer.
人乳头瘤病毒33型E7肽由HLA-DR*0402呈递给宫颈癌中的肿瘤浸润性T细胞。
J Virol. 2000 Jul;74(14):6632-6. doi: 10.1128/jvi.74.14.6632-6636.2000.
4
Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity.人乳头瘤病毒16型E7 DNA疫苗:E7开放阅读框中的突变增强特异性细胞毒性T淋巴细胞诱导及抗肿瘤活性。
J Virol. 1999 Sep;73(9):7877-81. doi: 10.1128/JVI.73.9.7877-7881.1999.
5
Immunomanipulative strategies for the control of human papillomavirus associated cervical disease.用于控制人乳头瘤病毒相关宫颈疾病的免疫调控策略
Immunol Res. 1997;16(4):387-400. doi: 10.1007/BF02786401.
6
Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts.浸润尖锐湿疣的人乳头瘤病毒6型特异性T细胞的分离与鉴定
J Virol. 1997 Sep;71(9):6427-32. doi: 10.1128/JVI.71.9.6427-6432.1997.
7
T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia.T细胞对16型人乳头瘤病毒肽的增殖反应:与宫颈上皮内瘤变的关系
Clin Diagn Lab Immunol. 1996 Mar;3(2):205-10. doi: 10.1128/cdli.3.2.205-210.1996.
8
Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.与原发性肿瘤相比,宫颈癌淋巴结转移中MHC和TAP-1表达的差异。
Br J Cancer. 1994 Jun;69(6):1176-81. doi: 10.1038/bjc.1994.231.
9
Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein.针对人乳头瘤病毒1型E4蛋白的人增殖性T细胞克隆的产生与特性分析
J Virol. 1993 May;67(5):2799-806. doi: 10.1128/JVI.67.5.2799-2806.1993.
10
A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.一种由“ISCAR”免疫载体与人乳头瘤病毒16型E7宫颈癌相关蛋白的肽表位组成的疫苗偶联物,在无油基佐剂的情况下,能在免疫小鼠中引发特异性Th1型和Th2型反应。
Clin Exp Immunol. 1995 Aug;101(2):265-71. doi: 10.1111/j.1365-2249.1995.tb08349.x.